LANTHEUS HOLDINGS INC (LNTH)
US5165441032 - Common Stock
LANTHEUS HOLDINGS INC
NASDAQ:LNTH (7/26/2024, 1:28:58 PM)
113.875
+0.92 (+0.82%)
Company Profile
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 834 full-time employees. The company went IPO on 2015-06-25. The firm classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.
Company Info
LANTHEUS HOLDINGS INC
331 Treble Cove Rd
North Billerica MASSACHUSETTS 01862
P: 19786718001
CEO: Mary Anne Heino
Employees: 834
Website: https://www.lantheus.com/
LNTH News
4 days ago - ChartmillNASDAQ:LNTH stands out as a growth opportunity that won't break the bank.Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
9 days ago - Lantheus Holdings, Inc.Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time9 days ago - Lantheus Holdings, Inc.Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern TimeBEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...
11 days ago - Lantheus Holdings, Inc.Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s DiseaseAcquisition Expands Pipeline and Strengthens Alzheimer’s Diagnostic Capabilities
11 days ago - Lantheus Holdings, Inc.Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s DiseaseAcquisition Expands Pipeline and Strengthens Alzheimer’s Diagnostic Capabilities...
14 days ago - Investor's Business DailyStock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly ReviewMegacaps and chip plays tumbled Thursday, but mostly still have healthy charts.
LNTH Twits
Here you can normally see the latest stock twits on LNTH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
